Table 1.
Vaccine | Vaccine platform | Viral antigens | Stage |
---|---|---|---|
Towne | Attenuated | Whole virus | Phase 2 |
gB/MF59 | Subunit protein | gB | Phase 2 |
TransVax | DNA vaccine | gB, pp65 | Phase 2 |
Vaccine | Vaccine platform | Viral antigens | Stage |
---|---|---|---|
Towne | Attenuated | Whole virus | Phase 2 |
gB/MF59 | Subunit protein | gB | Phase 2 |
TransVax | DNA vaccine | gB, pp65 | Phase 2 |